HR, M., M, B., & SI, R. (2014). Valnoctamide, a non-teratogenic amide derivative of valproic acid, inhibits arachidonic acid activation in vitro by recombinant acyl-CoA synthetase-4. Bipolar disorders, 16(8), 875. https://doi.org/10.1111/bdi.12220
Chicago Style (17th ed.) CitationHR, Modi, Basselin M, and Rapoport SI. "Valnoctamide, a Non-teratogenic Amide Derivative of Valproic Acid, Inhibits Arachidonic Acid Activation in Vitro by Recombinant Acyl-CoA Synthetase-4." Bipolar Disorders 16, no. 8 (2014): 875. https://doi.org/10.1111/bdi.12220.
MLA (9th ed.) CitationHR, Modi, et al. "Valnoctamide, a Non-teratogenic Amide Derivative of Valproic Acid, Inhibits Arachidonic Acid Activation in Vitro by Recombinant Acyl-CoA Synthetase-4." Bipolar Disorders, vol. 16, no. 8, 2014, p. 875, https://doi.org/10.1111/bdi.12220.